about
Functional Selectivity and Classical Concepts of Quantitative PharmacologyDopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclaseFunctional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophsThe perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsMicrostructural changes in the substantia nigra of asymptomatic agricultural workersBlunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptorsBehavioural assessment of mice lacking D1A dopamine receptorsLow affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptorsHeterotypic sprouting of serotonergic forebrain fibers in the brindled mottled mutant mouseSKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase CReply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?A novel role of CDX1 in embryonic epicardial development.Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.Asymmetrical lateral ventricular enlargement in Parkinson's disease.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.Synthesis and SAR exploration of dinapsoline analogues.8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.Transcriptional repression by the BRG1-SWI/SNF complex affects the pluripotency of human embryonic stem cells.Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?Apolipoprotein E genotypes and the risk of Parkinson diseaseStatins, plasma cholesterol, and risk of Parkinson's disease: a prospective studyLower low-density lipoprotein cholesterol levels are associated with Parkinson's diseaseT1 Relaxation Rate (R1) Indicates Nonlinear Mn Accumulation in Brain Tissue of Welders With Low-Level Exposure.D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease.Higher iron in the red nucleus marks Parkinson's dyskinesia.Increased R2* in the Caudate Nucleus of Asymptomatic Welders.Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge.Triadimefon, a triazole fungicide, induces stereotyped behavior and alters monoamine metabolism in rats.Responses of dopaminergic and serotonergic systems to triethyllead intoxication.Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.Importance of the Locus coeruleus and involvement of alpha-adrenergic receptors in the post-decapitation reflex in the rat.Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs.Triadimefon and triadimenol: effects on monoamine uptake and release.
P50
Q22242288-39404B36-AC73-41F1-A900-EB97D3E70B57Q26864383-DEC6A798-526D-4C22-8165-C55C42ECF104Q28218669-809EE51E-9836-458D-A557-1F42F307C247Q28218678-5B86A5F9-CD61-4561-BA4D-31E4E8C2690FQ28396222-E8CA8E33-5734-4862-9348-F995E37B6715Q28397004-9DCCEC05-E255-4F00-A450-258755C5BADDQ28505790-E1B07B37-A5A4-4C1E-A113-A3D4F2497BDFQ28506674-BFFF5B8B-A706-4D34-825A-29296F8C224CQ28585319-F5B46EBE-80C5-406B-BAD1-04883E60DA17Q28591147-2560DB29-5902-4BC9-980B-9974C8437BCFQ30400003-372A7CE8-1116-467C-9E62-042B63A56C3FQ33348468-F171159C-232A-4CF5-9AC9-B205BB298A22Q33961259-E4E65EF4-6500-4985-8A7A-755C7FDFC651Q33966353-A824A3C6-4AED-4AF0-8450-413D9FAFB776Q33996828-DB5D540A-B51F-43B7-AA50-6BFF28B2A9BCQ34012649-C7CBD47F-DDD5-4216-91F9-42A9A3E1E1A1Q34243731-F8B272BC-4B10-47F3-8494-0CF0782FF66DQ34294558-476D7F54-F4AC-4A44-A1C3-698F1236D076Q34305569-207D65D0-ADE4-44EF-B774-80CFD0AF03C2Q34471347-9EB073C9-4BCE-42E5-82E2-B0B903A6A95CQ34699719-E8003DBA-5569-49F3-B7BC-C76E849CDBF5Q35012574-45F6CE1A-781C-4F6D-87B0-7A306D598CD5Q35211228-67FC82E0-0C43-4F41-AC0B-6EF792713952Q35328089-F6670D6A-7CC3-4DA1-BC70-DEDB4D2F9FA8Q35869176-218C7C87-8BF9-4770-83AD-E6C17E311EDFQ36167543-CB344828-2A84-4ABC-96B8-60F38E9B27B4Q36512884-D2817C6E-BABD-4847-890A-2D04BDB2F8A6Q36605028-1F73A1E1-EF97-42CB-B3F5-1AFCC09B09FEQ36871031-7C03F5BC-8454-4BAD-9479-301058594D2AQ38762256-FBEF407E-583D-42B5-9B33-A3D7C8ECF963Q39749438-07F1A536-D547-44E4-BAB7-77E73BAD1A63Q41136901-33E18258-93AA-420C-A37B-2A0A9DAE3349Q41226021-FC2FBE61-16F5-4E52-AC98-756B7370F9CBQ41255475-3D2E04E2-F12D-4960-8145-606D2B283598Q41286471-F2C6CCD7-E7B8-432D-98C3-9CAD288D5AC6Q41316325-2BF45E87-938F-41DD-A02A-02938C6BAE0FQ41549832-0E159CC2-3006-44CB-8AF3-5EB8CDC483BBQ42451363-7277E364-CB9A-4932-B5EE-5B9AF0FA664BQ42523089-14C6EFD5-B435-4664-B3C5-D264FB2E2C4AQ42523196-0AA4C77F-62B2-4298-93F1-77ECE2366DEF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard Mailman
@ast
Richard Mailman
@en
Richard Mailman
@es
Richard Mailman
@nl
type
label
Richard Mailman
@ast
Richard Mailman
@en
Richard Mailman
@es
Richard Mailman
@nl
prefLabel
Richard Mailman
@ast
Richard Mailman
@en
Richard Mailman
@es
Richard Mailman
@nl
P106
P1153
7004614507
P2798
P31
P496
0000-0003-1353-2738